HIV/AIDS
MedMira Receives Russian Approval for Multiplo Test
Published in Hepatitis Weekly, June 11th, 2007
MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions, announced today that it has received regulatory approval from the health ministry in the Russian Federation for its Multiplo(tm) Rapid HBV/HIV/HCV Antibody Test (Multiplo HBV/HIV/HCV). MedMira's MultiploTM product line uses its patent-pending MutiploTM platform, and represents the newest generation of rapid diagnostic tests which can simultaneously detect multiple disease markers in minutes. Multiplo HBV/HIV/HCV detects antibodies to HIV and/or the Hepatitis B and C viruses that may be present in a blood sample, and is the first test in the MultiploTM line to receive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-06-11)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Hepatitis B Patients' Understanding of the Disease is Deficient - Hepatitis B Virus
Retrospective observational study shows combination vaccines may improve vaccination coverage rates in infants - Gene Therapy
Study results from Second Military Medical University, Department of Medical Genetics broaden understanding of gene therapy - Hepatitis A Vaccines
Studies from Centers for Disease Control and Prevention yield new data on hepatitis a vaccines - Hepatitis B Virus Immunology
New hepatitis B virus immunology study results from National Laboratory of Biomacromolecules described - Hepatitis B Virus Vaccines
Research from University of Padova provides new data on hepatitis B virus vaccines - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
